To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C20orf11TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
543 supporting clones for gene C20orf11 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG755041 B-cells, primary B-cells from tonsils (cell line) .a 1 to 247 1 to 247   tiling clone,   247/272
(90 %)
5 diff
(98.2 %id)
BP333204 salivary gland .a 179 to 736 1 to 558       558/558
(100 %)
5 diff
(99.2 %id)
CD676269 eye, lens .a 194 to 772 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
CN427595 embryonic stem cells, cell lines H1, H7, andH9 .a 199 to 348 1 to 150       150/150
(100 %)
3 diff
(98.0 %id)
CN427598 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 207 to 395 1 to 189       189/189
(100 %)
0 diff
(100 %id)
BX349965 Neuroblastoma Cot 50-normalized .a 226 to 1032 801 to 1       801/801
(100 %)
18 diff
(97.8 %id)
BX349966 Neuroblastoma Cot 50-normalized .a 226 to 1032 805 to 1       805/805
(100 %)
13 diff
(98.4 %id)
NM_017896.2   .a 226 to 4650 1 to 4425 exact RefSeq, AAA   4425/4425
(100 %)
0 diff
(100 %id)
BM841917 myeloma .a 237 to 473 1 to 237       237/237
(100 %)
0 diff
(100 %id)
BM851638 myeloma .a 237 to 745 1 to 509       509/509
(100 %)
0 diff
(100 %id)
BM848250 myeloma .a 237 to 784 1 to 548       548/548
(100 %)
0 diff
(100 %id)
BM849236 myeloma .a 237 to 904 1 to 668   tiling clone,   668/668
(100 %)
0 diff
(100 %id)
BG611433 adenocarcinoma, Prostate .a 253 to 859 1 to 622       622/831
(74 %)
31 diff
(96.3 %id)
BF307289 muscle, rhabdomyosarcoma .a 255 to 968 1 to 710       710/1028
(69 %)
18 diff
(98.3 %id)
DA809749 brain .a 255 to 890 2 to 638   capped   637/637
(100 %)
1 diff
(99.9 %id)
BC032120 Muscle, rhabdomyosarcoma .a 256 to 1807 1 to 1552 V59L tiling clone, available from MGC, AAA   1552/1552
(100 %)
2 diff
(99.9 %id)
DN993594 brain, whole brain .a 264 to 792 8 to 536       529/536
(98 %)
6 diff
(98.9 %id)
BP354488   .a 267 to 848 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB236255 trachea .a 268 to 813 2 to 547   capped   546/546
(100 %)
2 diff
(99.7 %id)
DA214136 brain .a 277 to 763 2 to 490   capped   489/489
(100 %)
3 diff
(99.4 %id)
DA811472 brain .a 277 to 767 2 to 494   capped   493/493
(100 %)
5 diff
(99.0 %id)
BG708883 brain, hypothalamus .a 279 to 1106 1 to 816 F160S G161E D162T L163S L164S ...     816/904
(90 %)
37 diff
(96.0 %id)
BI598240 brain, hypothalamus .a 279 to 1111 1 to 830 D218T L219S S220A K221R G222C ...     830/833
(99 %)
9 diff
(99.0 %id)
BP205502 coronary artery .a 284 to 862 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
TI_45210966   .a 284 to 1111 93 to 917 D218T L219S S220A K221R G222C ...     825/920
(89 %)
11 diff
(98.9 %id)
DA230340 brain .a 285 to 844 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA457267 tongue, tumor tissue .a 285 to 837 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DB132956 thymus .a 285 to 837 2 to 552   capped   551/551
(100 %)
3 diff
(99.5 %id)
DB228227 trachea .a 285 to 858 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DB228244 trachea .a 285 to 859 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DB286357 uterus .a 285 to 829 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
BM016811 astrocytoma grade IV, cell line, brain .a 287 to 1114 1 to 836 L150A A151G F152L D153*     836/837
(99 %)
14 diff
(98.4 %id)
DA775119 brain .a 287 to 862 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
BM843075 lymph node, stomach .a 287 to 841 1 to 555       555/555
(100 %)
0 diff
(100 %id)
DA432932 cord Blood .a 288 to 838 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DB501052 hypothalamus .a 288 to 783 1 to 496       496/496
(100 %)
0 diff
(100 %id)
TI_59387047   .a 288 to 1114 104 to 938 L150A A151G F152L D153*     835/836
(99 %)
13 diff
(98.5 %id)
DA758747   .a 288 to 834 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA852496 placenta .a 288 to 840 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DA992402 synovial membrane tissue from rheumatioidarthritis .a 288 to 838 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
DA992440 synovial membrane tissue from rheumatioidarthritis .a 288 to 833 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
DB011060 colon, tumor tissue .a 288 to 853 2 to 569   capped   568/568
(100 %)
5 diff
(99.2 %id)
DB037345 testis .a 288 to 862 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DB067391 testis .a 288 to 837 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
DB072732 testis .a 288 to 826 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
DB136783 thymus .a 288 to 842 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DB219137 trachea .a 288 to 834 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
AK000609   .a 290 to 1807 1 to 1516 exact available from FLJ, AAA   1516/1516
(100 %)
1 diff
(100.0 %id)
BP272944   .a 290 to 862 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
BP273283   .a 290 to 854 1 to 565       565/565
(100 %)
4 diff
(99.3 %id)
BM848307 myeloma .a 290 to 784 1 to 495       495/495
(100 %)
0 diff
(100 %id)
DA416179 thalamus .a 291 to 856 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA433792 tongue, tumor tissue .a 291 to 1012 2 to 724   capped   723/723
(100 %)
2 diff
(99.8 %id)
DA725527   .a 291 to 843 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
BM845899 myeloma .a 291 to 770 1 to 480       480/480
(100 %)
2 diff
(99.6 %id)
DB074947 testis .a 291 to 797 2 to 509   capped   508/508
(100 %)
1 diff
(99.9 %id)
DB223616 trachea .a 291 to 849 2 to 563   capped   562/562
(100 %)
4 diff
(99.3 %id)
DB287145 uterus .a 291 to 837 2 to 549   capped   548/549
(99 %)
3 diff
(99.5 %id)
BP351377   .a 293 to 874 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CN427597 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 295 to 904 1 to 610       610/610
(100 %)
3 diff
(99.6 %id)
AL524750 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 302 to 1176 1 to 853 E131D Q132R G133A E134R E135R ... fully sequenced,   853/853
(100 %)
9 diff
(99.0 %id)
AW514956 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 305 to 909 1 to 605     Submitted on the opposite strand 605/605
(100 %)
5 diff
(99.2 %id)
AI193740 lung .a 306 to 717 1 to 412     Submitted on the opposite strand 412/415
(99 %)
1 diff
(99.8 %id)
AI384030 B-cell, chronic lymphotic leukemia .a 306 to 832 1 to 527     Submitted on the opposite strand 527/527
(100 %)
0 diff
(100 %id)
AI419679 brain, glioblastoma (pooled) .a 306 to 434 1 to 129     Submitted on the opposite strand 129/143
(90 %)
1 diff
(99.4 %id)
AI819783 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 306 to 1060 1 to 752     Submitted on the opposite strand 752/754
(99 %)
16 diff
(97.9 %id)
BE044338 pooled .a 306 to 796 1 to 490     Submitted on the opposite strand 490/490
(100 %)
1 diff
(99.8 %id)
AW139895   .a 307 to 788 1 to 482     Submitted on the opposite strand 482/482
(100 %)
0 diff
(100 %id)
BI838141 pooled pancreas and spleen .a 308 to 1043 1 to 733       733/733
(100 %)
9 diff
(98.8 %id)
BX382499 Placenta Cot 25-normalized .a 309 to 1225 915 to 1 exact   Submitted on the opposite strand 915/915
(100 %)
2 diff
(99.8 %id)
BI907507 leukocyte .a 309 to 1067 1 to 762       762/762
(100 %)
22 diff
(97.2 %id)
TI_57163275   .a 309 to 1043 40 to 771       732/771
(94 %)
12 diff
(98.5 %id)
BU152961 large cell carcinoma, lung .a 314 to 1075 1 to 773       773/866
(89 %)
29 diff
(96.7 %id)
TI_57234067   .a 314 to 1067 35 to 791       757/791
(95 %)
21 diff
(97.4 %id)
CN427594 embryonic stem cells, cell lines H1, H7, andH9 .a 323 to 978 1 to 656       656/656
(100 %)
4 diff
(99.4 %id)
W17226 lung .a 323 to 713 1 to 388       369/457
(80 %)
11 diff
(97.6 %id)
AI026637   .a 324 to 741 1 to 418     Submitted on the opposite strand 418/418
(100 %)
3 diff
(99.3 %id)
AI334072 lung .a 324 to 726 1 to 403     Submitted on the opposite strand 403/403
(100 %)
1 diff
(99.8 %id)
AI942424 Kidney .a 324 to 790 1 to 468     Submitted on the opposite strand 468/468
(100 %)
7 diff
(98.6 %id)
AI808941 B-cell, chronic lymphotic leukemia .a 325 to 867 1 to 542     Submitted on the opposite strand 542/542
(100 %)
12 diff
(97.8 %id)
T50079 placenta .a 334 to 625 6 to 301     Submitted on the opposite strand 296/301
(98 %)
11 diff
(96.4 %id)
AI820015 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 342 to 925 1 to 584     Submitted on the opposite strand 584/589
(99 %)
6 diff
(99.0 %id)
AI479110 B-cell, chronic lymphotic leukemia .a 345 to 1035 1 to 691     Submitted on the opposite strand 691/691
(100 %)
10 diff
(98.6 %id)
BQ777181 Pancreas, Purified pancreatic islet .a 345 to 950 606 to 1     Submitted on the opposite strand 606/606
(100 %)
0 diff
(100 %id)
BQ778296 Pancreas, Purified pancreatic islet .a 346 to 945 1 to 600     Submitted on the opposite strand 600/600
(100 %)
0 diff
(100 %id)
DA223022 brain .a 368 to 900 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA568464 whole embryo, mainly head .a 381 to 1074 2 to 697   capped   696/696
(100 %)
12 diff
(98.3 %id)
CX872728 embryonic stem .a 385 to 1144 1 to 760 K215X     760/760
(100 %)
0 diff
(100 %id)
AA748028 germinal center B cell .a 386 to 625 1 to 240     Submitted on the opposite strand 240/240
(100 %)
0 diff
(100 %id)
TI_1948216999   .a 386 to 833 107 to 554       448/458
(97 %)
8 diff
(98.3 %id)
TI_1948217338   .a 386 to 917 114 to 647       534/1429
(37 %)
45 diff
(96.9 %id)
TI_1948217339   .a 386 to 809 107 to 530       424/434
(97 %)
7 diff
(98.4 %id)
TI_1948217957   .a 386 to 921 113 to 648       536/1498
(35 %)
11 diff
(99.3 %id)
TI_154186126   .a 390 to 1295 136 to 1028 N177T Q178K A179L V180C L181*     893/1009
(88 %)
42 diff
(95.9 %id)
TI_154186187   .a 390 to 1145 134 to 873 P155X N177T Q178K A179L V180C ...     740/938
(78 %)
24 diff
(97.5 %id)
AA648739 germinal center B cell .a 392 to 789 1 to 398     Submitted on the opposite strand 398/398
(100 %)
1 diff
(99.8 %id)
AA765794 germinal center B cell .a 393 to 748 1 to 356     Submitted on the opposite strand 356/356
(100 %)
2 diff
(99.5 %id)
BM740279 Ascites, stomach .a 393 to 778 1 to 384       384/384
(100 %)
2 diff
(99.5 %id)
DB218615 trachea .a 397 to 930 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
BQ959321 epidermoid carcinoma, cell line, lung .a 398 to 1304 1 to 910 exact     910/912
(99 %)
8 diff
(99.2 %id)
CN427596 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 403 to 883 1 to 481       481/481
(100 %)
0 diff
(100 %id)
EL735252 mixed .a 403 to 991 1 to 588       588/588
(100 %)
4 diff
(99.4 %id)
AA130422 colon, tumor .a 408 to 857 1 to 451       451/452
(99 %)
6 diff
(98.7 %id)
CB120776 cervix, Uterine .a 409 to 999 1 to 591       591/591
(100 %)
0 diff
(100 %id)
BI116324 lung, small cell carcinoma .a 425 to 1261 11 to 854       844/855
(98 %)
27 diff
(96.9 %id)
AA460568   .a 444 to 881 1 to 437       437/437
(100 %)
2 diff
(99.6 %id)
BM272021 Pancreas, Purified pancreatic islet .a 454 to 1059 11 to 616       606/616
(98 %)
6 diff
(99.1 %id)
BP258164 heart .a 479 to 1058 1 to 580       580/580
(100 %)
13 diff
(97.8 %id)
TI_1948217000   .a 519 to 1088 696 to 125       572/1393
(41 %)
17 diff
(98.8 %id)
BG676116 skin, squamous cell carcinoma .a 531 to 906 1 to 377       377/594
(63 %)
2 diff
(99.7 %id)
BG468534 adenocarcinoma cell line, colon .a 532 to 1445 1 to 904       904/995
(90 %)
24 diff
(97.6 %id)
BM055324 Islets of Langerhans, Pancreas .a 537 to 1105 1 to 569       569/569
(100 %)
0 diff
(100 %id)
AA031751 uterus .a 547 to 918 384 to 3     Submitted on the opposite strand 382/384
(99 %)
40 diff
(89.6 %id)
AA767045 germinal center B cell .a 549 to 660 1 to 112     Submitted on the opposite strand 112/112
(100 %)
0 diff
(100 %id)
BQ424637 melanotic melanoma, skin .a 568 to 1414 1 to 857       857/883
(97 %)
17 diff
(98.1 %id)
CN427592 embryonic stem cells, DMSO-treated H9 cellline .a 616 to 959 1 to 344       344/344
(100 %)
0 diff
(100 %id)
FN075469 breast carcinoma .a 631 to 685 55 to 1     Submitted on the opposite strand 55/55
(100 %)
0 diff
(100 %id)
DA785545 brain .a 631 to 1195 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
AW368582 head_neck .a 633 to 1147 515 to 1       515/600
(85 %)
13 diff
(97.9 %id)
BM458188 leiomyosarcoma, uterus .a 634 to 1598 1 to 977       977/1030
(94 %)
23 diff
(97.8 %id)
AW368510 head_neck .a 637 to 1224 24 to 608       585/620
(94 %)
15 diff
(97.6 %id)
AW853616 colon .a 637 to 1160 1 to 523       523/523
(100 %)
16 diff
(97.0 %id)
BE889956 leiomyosarcoma, uterus .a 642 to 1372 1 to 726       726/952
(76 %)
12 diff
(98.8 %id)
AW361238 colon .a 651 to 1217 1 to 561       561/569
(98 %)
28 diff
(95.1 %id)
BG290049 bladder, transitional cell papilloma, cell line .a 651 to 1379 1 to 732       732/950
(77 %)
15 diff
(98.5 %id)
AW578474 colon .a 656 to 1209 33 to 579       547/579
(94 %)
13 diff
(97.8 %id)
BE740654 adenocarcinoma cell line, ovary .a 661 to 1528 1 to 859       859/942
(91 %)
24 diff
(97.5 %id)
DA760478   .a 668 to 1207 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA238013 brain .a 699 to 1273 10 to 585   capped   576/584
(98 %)
1 diff
(99.9 %id)
BG682077 skin, squamous cell carcinoma .a 700 to 1356 1 to 660       660/938
(70 %)
16 diff
(98.3 %id)
BM452897 melanotic melanoma, skin .a 705 to 1558 25 to 881       857/884
(96 %)
13 diff
(98.6 %id)
FN068236 breast carcinoma .a 707 to 786 80 to 1     Submitted on the opposite strand 80/85
(94 %)
6 diff
(93.0 %id)
BE764126 nervous_tumor .a 708 to 1213 12 to 516       505/520
(97 %)
11 diff
(97.9 %id)
BM804056 embryonal carcinoma, cell line, testis .a 708 to 1387 1 to 686       686/955
(71 %)
17 diff
(98.3 %id)
AW853618 colon .a 716 to 1208 491 to 1       491/491
(100 %)
2 diff
(99.6 %id)
TI_159708097   .a 716 to 1618 1042 to 150   AAA   893/1156
(77 %)
21 diff
(98.2 %id)
AI904239 breast .a 732 to 1217 496 to 13       484/496
(97 %)
0 diff
(100 %id)
W89165 liver and spleen .a 739 to 1178 1 to 441       441/443
(99 %)
10 diff
(97.8 %id)
AW753267 colon .a 743 to 1081 1 to 341       339/341
(99 %)
28 diff
(91.8 %id)
CV812434 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 756 to 1590 860 to 20   AAA Submitted on the opposite strand 841/857
(98 %)
30 diff
(96.5 %id)
TI_154127279   .a 768 to 1590 907 to 90   AAA   818/999
(81 %)
17 diff
(98.3 %id)
DA798485 brain .a 779 to 1286 2 to 508   capped   507/507
(100 %)
1 diff
(99.9 %id)
CF138138 lymph .a 794 to 1241 1 to 448       448/448
(100 %)
4 diff
(99.2 %id)
TI_154167949   .a 799 to 1395 91 to 693       603/931
(64 %)
22 diff
(97.7 %id)
CN427593 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 801 to 1352 1 to 552       552/552
(100 %)
6 diff
(99.0 %id)
BX376544 Neuroblastoma Cot 50-normalized .a 805 to 1776 974 to 4       971/974
(99 %)
14 diff
(98.6 %id)
CD675980 eye, lens .a 809 to 1453 1 to 645       645/645
(100 %)
0 diff
(100 %id)
R94122 liver and spleen .a 810 to 1104 1 to 294       294/294
(100 %)
5 diff
(98.3 %id)
BY797259 eye .a 816 to 1380 1 to 565       565/565
(100 %)
0 diff
(100 %id)
N91638 liver and spleen .a 819 to 1266 1 to 451       451/451
(100 %)
9 diff
(98.1 %id)
DA437348 tongue, tumor tissue .a 822 to 1411 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
T34585 blood, white blood cells .a 836 to 1141 1 to 308       308/308
(100 %)
2 diff
(99.4 %id)
AL698806 human skeletal muscle .a 868 to 1409 1 to 541       541/541
(100 %)
1 diff
(99.9 %id)
CD678291 eye, Trabecular meshwork .a 871 to 1375 1 to 505       505/505
(100 %)
0 diff
(100 %id)
DA756964   .a 879 to 1459 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
AW175609 breast .a 887 to 1236 351 to 2       350/354
(98 %)
1 diff
(99.8 %id)
CA417003 Chondrosarcoma Cell line .a 901 to 1590 710 to 19   AAA   692/692
(100 %)
3 diff
(99.6 %id)
AW753233 colon .a 914 to 1181 268 to 4       265/277
(95 %)
0 diff
(100 %id)
DA231370 brain .a 914 to 1445 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
BX372925 Neuroblastoma Cot 50-normalized .a 916 to 1801 891 to 1       891/891
(100 %)
57 diff
(93.7 %id)
BQ320164 colon .a 920 to 1220 314 to 15       300/314
(95 %)
0 diff
(100 %id)
AW264290 brain, three pooled meningiomas .a 928 to 1590 662 to 1       662/662
(100 %)
4 diff
(99.4 %id)
BP207746 coronary artery .a 935 to 1497 1 to 563       563/564
(99 %)
7 diff
(98.8 %id)
BF792776 adrenal cortex carcinoma, cell line, adrenal gland .a 937 to 1577 1 to 641       641/908
(70 %)
15 diff
(98.4 %id)
DB226853 trachea .a 950 to 1479 2 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
BM717940 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 952 to 1573 1 to 621       621/635
(97 %)
1 diff
(99.9 %id)
T30415 colon, endothelial .a 958 to 1200 1 to 243       243/248
(97 %)
1 diff
(99.6 %id)
AW967272   .a 959 to 1377 1 to 419       419/419
(100 %)
16 diff
(96.2 %id)
AW967273   .a 959 to 1541 1 to 582       582/582
(100 %)
9 diff
(98.5 %id)
BG683350 brain, neuroblastoma, cell line .a 959 to 1606 1 to 650       650/652
(99 %)
10 diff
(98.5 %id)
BE163534 head_neck .a 972 to 1466 494 to 2     Submitted on the opposite strand 493/494
(99 %)
0 diff
(100 %id)
BF229833 colon_est .a 978 to 1409 23 to 455       433/455
(95 %)
6 diff
(98.7 %id)
BI041406 nervous_tumor .a 979 to 1211 1 to 233       233/241
(96 %)
12 diff
(95.1 %id)
M79033   .a 979 to 1266 1 to 288       288/288
(100 %)
0 diff
(100 %id)
M79034   .a 979 to 1325 1 to 349       349/349
(100 %)
2 diff
(99.5 %id)
BE163526 head_neck .a 982 to 1459 48 to 525       478/525
(91 %)
6 diff
(98.9 %id)
DA340237 hippocampus .a 986 to 1522 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DB100456 testis .a 987 to 1511 2 to 526   capped   525/525
(100 %)
2 diff
(99.7 %id)
W88489 liver and spleen .a 988 to 1431 1 to 446   fully sequenced,   446/446
(100 %)
10 diff
(97.8 %id)
CX762889 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 996 to 1821 816 to 1       816/823
(99 %)
18 diff
(97.9 %id)
CA310527 Human Lung Epithelial cells, lung .a 1006 to 1807 815 to 19   AAA   797/797
(100 %)
5 diff
(99.4 %id)
R23586 placenta .a 1010 to 1428 1 to 429       429/429
(100 %)
16 diff
(96.3 %id)
BF038951 adenocarcinoma, ovary .a 1011 to 1598 1 to 587       587/587
(100 %)
16 diff
(97.3 %id)
TI_149303249   .a 1013 to 1817 882 to 84   AAA   799/973
(82 %)
12 diff
(98.8 %id)
AW405243 lymph .a 1026 to 1292 7 to 273       267/273
(97 %)
6 diff
(97.9 %id)
TI_154147777   .a 1026 to 1687 79 to 739       661/661
(100 %)
6 diff
(99.1 %id)
DA331128 hippocampus .a 1040 to 1592 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
BE087593 breast .a 1051 to 1252 199 to 1     Submitted on the opposite strand 199/199
(100 %)
2 diff
(99.0 %id)
BF927996 nervous_tumor .a 1059 to 1414 16 to 375       360/375
(96 %)
6 diff
(98.4 %id)
BQ575682 Chondrosarcoma Grade II, Left Pelvis .a 1060 to 1807 760 to 19   AAA   742/742
(100 %)
7 diff
(99.1 %id)
BF762753 colon_est .a 1064 to 1412 18 to 364       347/379
(91 %)
10 diff
(97.4 %id)
CA426714 cell lines, Chondrosarcoma .a 1065 to 1728 682 to 19   AAA   664/664
(100 %)
3 diff
(99.6 %id)
F18986 pectoral muscle (after mastectomy) .a 1077 to 1433 1 to 357       357/357
(100 %)
0 diff
(100 %id)
BP428967   .a 1078 to 1468 404 to 2       403/404
(99 %)
0 diff
(100 %id)
DB238123 trachea .a 1084 to 1658 10 to 585   capped   576/584
(98 %)
6 diff
(99.0 %id)
TI_154100464   .a 1094 to 1814 802 to 90   AAA   713/716
(99 %)
13 diff
(98.2 %id)
W65456 heart .a 1104 to 1513 1 to 412   fully sequenced,   412/412
(100 %)
5 diff
(98.8 %id)
DA739242   .a 1113 to 1628 2 to 515   capped   514/514
(100 %)
2 diff
(99.7 %id)
BM981291 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1126 to 1817 708 to 19   AAA   690/690
(100 %)
4 diff
(99.5 %id)
BF055143 pooled .a 1131 to 1593 469 to 7       463/469
(98 %)
0 diff
(100 %id)
BP431167   .a 1131 to 1468 338 to 1       338/338
(100 %)
0 diff
(100 %id)
AI808513 pooled .a 1132 to 1585 490 to 35   AAA   456/456
(100 %)
15 diff
(96.8 %id)
CV411996 colon_est .a 1141 to 1418 291 to 10     Submitted on the opposite strand 282/302
(93 %)
0 diff
(100 %id)
CA314797 Human Lung Epithelial cells, lung .a 1141 to 1807 685 to 19   AAA   667/667
(100 %)
2 diff
(99.8 %id)
BU630095 cell lines, Chondrosarcoma .a 1141 to 1817 694 to 19   AAA   676/676
(100 %)
1 diff
(99.9 %id)
BF761084 colon_est .a 1143 to 1418 286 to 10     Submitted on the opposite strand 277/286
(96 %)
0 diff
(100 %id)
BF761384 colon_est .a 1143 to 1418 282 to 8     Submitted on the opposite strand 275/282
(97 %)
0 diff
(100 %id)
AL524749 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1146 to 1763 637 to 24   fully sequenced,   614/637
(96 %)
18 diff
(97.2 %id)
BQ000910 lung, Metastatic Chondrosarcoma .a 1171 to 1807 653 to 19   AAA   635/635
(100 %)
8 diff
(98.8 %id)
TI_154178581   .a 1196 to 1809 691 to 80     Submitted on the opposite strand 612/859
(71 %)
0 diff
(100 %id)
TI_149277032   .a 1199 to 1817 73 to 689     Submitted on the opposite strand 617/1106
(55 %)
8 diff
(99.3 %id)
BU677454 lung, Primary Lung Epithelial Cells .a 1199 to 1782 5 to 587     Submitted on the opposite strand 583/587
(99 %)
6 diff
(99.0 %id)
AI688742 pooled .a 1204 to 1585 398 to 16   AAA   383/383
(100 %)
6 diff
(98.5 %id)
CA433132 mixed .a 1206 to 1807 618 to 19   AAA   600/600
(100 %)
5 diff
(99.2 %id)
DB138339 thymus .a 1208 to 1690 2 to 484   capped   483/483
(100 %)
3 diff
(99.4 %id)
BM988791 lung, Lung Focal Fibrosis .a 1212 to 1590 397 to 19   AAA   379/379
(100 %)
0 diff
(100 %id)
BG107895 Bone, osteosarcoma, cell line .a 1223 to 1815 1 to 591   AAA   591/604
(97 %)
18 diff
(97.1 %id)
CA441413 Fibrosarcoma .a 1225 to 1814 607 to 19   AAA   589/589
(100 %)
2 diff
(99.7 %id)
BF747782 breast .a 1238 to 1420 1 to 184       184/192
(95 %)
10 diff
(94.8 %id)
DB354973 whole embryo, mainly head .a 1245 to 1807 572 to 1       572/572
(100 %)
32 diff
(94.5 %id)
AA461493   .a 1253 to 1590 351 to 15   AAA   337/337
(100 %)
1 diff
(99.8 %id)
AA191749   .a 1260 to 1807 576 to 36   AAA   541/546
(99 %)
12 diff
(97.9 %id)
AW241869 pooled .a 1284 to 1730 446 to 1       446/446
(100 %)
2 diff
(99.6 %id)
AW316901 adenocarcinoma, Pancreas .a 1296 to 1809 514 to 1       514/514
(100 %)
0 diff
(100 %id)
BM271703 Pancreas, Purified pancreatic islet .a 1320 to 1808 489 to 1       489/489
(100 %)
0 diff
(100 %id)
DB572230 hypothalamus .a 1322 to 1810 1 to 488     Submitted on the opposite strand 488/488
(100 %)
2 diff
(99.6 %id)
AI239753 pooled .a 1326 to 1730 404 to 1       404/404
(100 %)
2 diff
(99.6 %id)
TI_45236049   .a 1326 to 1820 62 to 554       493/1121
(43 %)
24 diff
(97.9 %id)
BI517860 pooled colon, kidney, stomach .a 1329 to 1820 1 to 490       490/1057
(46 %)
23 diff
(97.9 %id)
BU527756 epidermoid carcinoma, cell line, lung .a 1335 to 2040 38 to 753       716/928
(77 %)
21 diff
(97.8 %id)
AA130423 colon, tumor .a 1337 to 1814 482 to 1       482/483
(99 %)
4 diff
(99.2 %id)
AA626002   .a 1337 to 1597 264 to 5       260/264
(98 %)
0 diff
(100 %id)
AW170109 cervix, tumor .a 1337 to 1817 491 to 11   AAA   481/481
(100 %)
2 diff
(99.6 %id)
EC442323 Prostate .a 1362 to 1454 16 to 108       93/111
(83 %)
2 diff
(98.2 %id)
AI375586   .a 1376 to 1821 449 to 3       447/449
(99 %)
0 diff
(100 %id)
AA587776 colon, colon tumor RER+ .a 1386 to 1807 431 to 11   AAA   421/421
(100 %)
1 diff
(99.8 %id)
AA938656 germinal center B cell .a 1387 to 1817 455 to 25   AAA   431/431
(100 %)
0 diff
(100 %id)
DB561588 hypothalamus .a 1388 to 1810 1 to 422     Submitted on the opposite strand 422/422
(100 %)
3 diff
(99.3 %id)
BF770029 epid_tumor .a 1398 to 1643 45 to 289       245/291
(84 %)
15 diff
(94.9 %id)
BU078700 Pancreas, Purified pancreatic islet .a 1400 to 1807 419 to 13   AAA   407/407
(100 %)
6 diff
(98.6 %id)
W90016 liver and spleen .a 1401 to 1807 408 to 1   fully sequenced,   408/408
(100 %)
2 diff
(99.6 %id)
W89166 liver and spleen .a 1401 to 1814 413 to 1       413/414
(99 %)
2 diff
(99.6 %id)
AA993110   .a 1450 to 1819 370 to 1       370/370
(100 %)
2 diff
(99.5 %id)
AI346146 adenocarcinoma, colon .a 1450 to 1808 376 to 19   AAA   358/369
(97 %)
7 diff
(98.2 %id)
BM055045 Islets of Langerhans, Pancreas .a 1450 to 1817 382 to 17   AAA   366/366
(100 %)
8 diff
(97.9 %id)
AA133738 uterus .a 1455 to 1535 1 to 84   fully sequenced,   84/84
(100 %)
0 diff
(100 %id)
DA810426 brain .a 1456 to 1995 2 to 541   capped   540/540
(100 %)
3 diff
(99.5 %id)
DA118972 cerebellum .a 1457 to 1963 2 to 508   capped   507/507
(100 %)
0 diff
(100 %id)
DA500283 brain .a 1457 to 2025 2 to 571   capped   570/571
(99 %)
2 diff
(99.7 %id)
N68745 liver and spleen .a 1461 to 1821 365 to 3       363/365
(99 %)
0 diff
(100 %id)
AI581628 colon .a 1463 to 1809 347 to 2       346/347
(99 %)
0 diff
(100 %id)
DA022896   .a 1470 to 2038 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA788609 brain .a 1471 to 1963 2 to 493   capped   492/492
(100 %)
1 diff
(99.8 %id)
AI749665 colon .a 1474 to 1809 340 to 3       338/340
(99 %)
0 diff
(100 %id)
DB135026 thymus .a 1474 to 2018 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
AA621360   .a 1475 to 1813 340 to 1       340/340
(100 %)
8 diff
(97.7 %id)
W65457 heart .a 1483 to 1814 334 to 1   fully sequenced,   334/334
(100 %)
1 diff
(99.8 %id)
BX482298   .a 1490 to 2049 1 to 559       559/559
(100 %)
2 diff
(99.7 %id)
N89729 lung .a 1492 to 1807 320 to 1       320/320
(100 %)
10 diff
(96.9 %id)
AA133739 uterus .a 1505 to 1807 303 to 1   fully sequenced,   303/303
(100 %)
0 diff
(100 %id)
DA777630 brain .a 1515 to 2080 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
AI349396 lung .a 1526 to 1817 317 to 26   AAA   292/292
(100 %)
2 diff
(99.4 %id)
DA913655   .a 1532 to 2107 2 to 580   capped   579/579
(100 %)
6 diff
(99.0 %id)
AA448263   .a 1533 to 1820 288 to 1       288/288
(100 %)
2 diff
(99.4 %id)
BQ188138 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1533 to 1809 279 to 2     Submitted on the opposite strand 278/283
(98 %)
0 diff
(100 %id)
BQ185311 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1535 to 1809 1 to 275     Submitted on the opposite strand 275/285
(96 %)
1 diff
(99.7 %id)
T82378 lung .a 1538 to 1628 1 to 93   fully sequenced,   93/93
(100 %)
0 diff
(100 %id)
N68670 liver and spleen .a 1539 to 1817 294 to 16   AAA   279/279
(100 %)
1 diff
(99.7 %id)
AA483300 colon .a 1548 to 1807 283 to 24   AAA   260/260
(100 %)
0 diff
(100 %id)
BU198016 ectopic and normal uterine endometrium .a 1553 to 1816 1 to 264   AAA   264/264
(100 %)
1 diff
(99.7 %id)
R32658 placenta .a 1553 to 1815 269 to 1       269/270
(99 %)
7 diff
(97.5 %id)
AA777344 liver and spleen .a 1553 to 2067 1 to 517     Submitted on the opposite strand 517/517
(100 %)
4 diff
(99.3 %id)
CF146190 CNCAP(3)T-225 cell line, Prostate .a 1553 to 1817 270 to 6     Submitted on the opposite strand 265/271
(97 %)
0 diff
(100 %id)
AW472988 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1569 to 1814 269 to 24   AAA   246/247
(99 %)
9 diff
(96.4 %id)
DA497355 brain .a 1574 to 2136 2 to 566   capped   565/565
(100 %)
4 diff
(99.3 %id)
DA490854 brain .a 1575 to 2028 2 to 456   capped   455/455
(100 %)
1 diff
(99.8 %id)
DA775683 brain .a 1576 to 2140 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA406661 thalamus .a 1584 to 2137 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
BQ935273 brain, neuroblastoma, cell line .a 1592 to 2516 1 to 933       933/944
(98 %)
23 diff
(97.6 %id)
T57819 lung .a 1598 to 1807 213 to 1   fully sequenced,   213/213
(100 %)
2 diff
(99.1 %id)
AA032251 uterus .a 1633 to 1807 175 to 1       175/176
(99 %)
0 diff
(100 %id)
DA781585 brain .a 1643 to 2214 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DB163392 thymus .a 1650 to 2210 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DA068182 cerebellum .a 1652 to 2224 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DN995130 brain, whole brain .a 1653 to 2239 7 to 593   tiling clone,   587/593
(98 %)
6 diff
(99.0 %id)
DR156003 human embryonic stem cells differentiated toan early endodermal cell type .a 1655 to 2149 1 to 494       494/494
(100 %)
2 diff
(99.6 %id)
EC460919 Prostate .a 1668 to 1782 1 to 112       112/112
(100 %)
5 diff
(95.6 %id)
DA413166 thalamus .a 1683 to 2230 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
BM970038 lung .a 1687 to 1807 137 to 19   AAA   119/142
(83 %)
2 diff
(98.6 %id)
BM017707 astrocytoma grade IV, cell line, brain .a 1692 to 2297 1 to 610       610/612
(99 %)
12 diff
(98.1 %id)
DA279912 corpus callosum .a 1693 to 2258 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
TI_59388278   .a 1693 to 2297 63 to 671       609/611
(99 %)
12 diff
(98.1 %id)
DB081269 testis .a 1701 to 2243 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DA696163   .a 1705 to 2270 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA778591 brain .a 1706 to 2282 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DB156492 thymus .a 1708 to 2283 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
C00547   .a 1748 to 1817 1 to 70       70/70
(100 %)
0 diff
(100 %id)
BQ931571 epidermoid carcinoma, cell line, lung .a 1749 to 2582 1 to 842       842/884
(95 %)
26 diff
(97.1 %id)
CN267857 embryonic stem cells, cell lines H1, H7, andH9 .a 1763 to 2464 1 to 702       702/702
(100 %)
2 diff
(99.8 %id)
DB083846 testis .a 1803 to 2349 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
BG740683 skin .a 1872 to 2664 1 to 798       798/798
(100 %)
15 diff
(98.2 %id)
BU195403 eye, retinoblastoma .a 1909 to 2816 19 to 933       915/933
(98 %)
6 diff
(99.4 %id)
BX385399   .a 1951 to 2704 1 to 759       759/767
(98 %)
16 diff
(98.0 %id)
BX387101   .a 1951 to 2697 1 to 736       736/844
(87 %)
58 diff
(93.2 %id)
BX445863 fetal liver, Liver .a 1951 to 2441 1 to 498       498/562
(88 %)
44 diff
(92.2 %id)
DA368156 subthalamic nucleus .a 2071 to 2634 2 to 566   tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
BE315439 adenocarcinoma cell line, ovary .a 2075 to 2627 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
BG288864 bladder, transitional cell papilloma, cell line .a 2081 to 2803 1 to 719       719/936
(76 %)
21 diff
(97.8 %id)
BF036414 adenocarcinoma, ovary .a 2090 to 2728 1 to 643       643/643
(100 %)
12 diff
(98.2 %id)
AW850952 colon .a 2106 to 2584 1 to 478       478/478
(100 %)
7 diff
(98.6 %id)
BG679003 skin, squamous cell carcinoma .a 2106 to 2701 1 to 596       596/598
(99 %)
3 diff
(99.5 %id)
BQ707751 Spleen .a 2153 to 3001 1 to 860       860/951
(90 %)
24 diff
(97.5 %id)
BM834946 stomach .a 2244 to 2671 1 to 428       428/428
(100 %)
1 diff
(99.8 %id)
DA532120 brain .a 2251 to 2856 2 to 607   capped   606/606
(100 %)
1 diff
(99.9 %id)
DA078606 cerebellum .a 2259 to 2835 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
TI_151762583   .a 2266 to 2748 535 to 53       483/1038
(46 %)
0 diff
(100 %id)
BM045704 carcinoma, cell line, Prostate .a 2267 to 3013 1 to 759       759/816
(93 %)
26 diff
(96.9 %id)
BM049324 carcinoma, cell line, Prostate .a 2267 to 2970 1 to 704       704/719
(97 %)
15 diff
(98.0 %id)
BQ936444 carcinoma, cell line, Prostate .a 2269 to 3063 1 to 801       801/977
(81 %)
19 diff
(98.1 %id)
BM930030 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2276 to 2744 1 to 469       469/469
(100 %)
2 diff
(99.6 %id)
DA513292 brain .a 2317 to 2797 2 to 482   capped   481/481
(100 %)
1 diff
(99.8 %id)
AK025775   .a 2333 to 4650 1 to 2318   tiling clone, available from FLJ, AAA   2318/2318
(100 %)
1 diff
(100.0 %id)
BX486518   .a 2343 to 3051 16 to 723       708/723
(97 %)
6 diff
(99.2 %id)
DB001774 breast, tumor tissue .a 2365 to 2908 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA986744 synovial membrane tissue from rheumatioidarthritis .a 2426 to 3002 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BX328388   .a 2427 to 3355 1 to 927       927/928
(99 %)
11 diff
(98.9 %id)
DA367142 subthalamic nucleus .a 2438 to 2976 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DB001918 breast, tumor tissue .a 2441 to 2969 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
BG756232 B-cells, primary B-cells from tonsils (cell line) .a 2470 to 3205 1 to 739       739/739
(100 %)
8 diff
(99.0 %id)
CD674862 eye, lens .a 2483 to 3145 1 to 663       663/663
(100 %)
0 diff
(100 %id)
DA954103 Spleen .a 2495 to 3067 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA054493 cerebellum .a 2511 to 3053 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA202551 brain .a 2563 to 3109 2 to 549   capped   548/548
(100 %)
5 diff
(99.1 %id)
DB127131 thymus .a 2567 to 3069 2 to 507   capped   506/506
(100 %)
3 diff
(99.5 %id)
DA898580 skeletal muscle .a 2583 to 3068 2 to 490   capped   489/489
(100 %)
4 diff
(99.2 %id)
BG028910 Bone, osteosarcoma, cell line .a 2604 to 3287 1 to 692       692/969
(71 %)
46 diff
(95.3 %id)
BC031819.
matches multiple genes
hypernephroma, cell line, Kidney, Kidney, hypernephroma .a 2606 to 4650 1 to 2045   tiling clone, available from MGC, AAA also hits gene SLC4A3 2045/2045
(100 %)
2 diff
(100.0 %id)
BE868614.
matches multiple genes
adenocarcinoma, colon, Colon, adenocarcinoma .a 2625 to 3319 1 to 728   available from MGC, also hits gene FBXO9 728/1052
(69 %)
56 diff
(94.7 %id)
BQ944527 epidermoid carcinoma, cell line, lung .a 2655 to 3560 1 to 908       908/909
(99 %)
9 diff
(99.1 %id)
BU527004 epidermoid carcinoma, cell line, lung .a 2655 to 3523 1 to 878       878/878
(100 %)
23 diff
(97.4 %id)
DA934379 Spleen .a 2688 to 3271 2 to 586   capped   585/585
(100 %)
3 diff
(99.5 %id)
DA646669 mammary gland .a 2689 to 3465 2 to 776   capped   775/775
(100 %)
11 diff
(98.6 %id)
CB158979 Liver .a 2691 to 3247 1 to 557       557/557
(100 %)
2 diff
(99.7 %id)
DA709438   .a 2707 to 3271 2 to 567   capped   566/566
(100 %)
5 diff
(99.2 %id)
BJ991580 hepatoblastoma .a 2710 to 3122 1 to 413       413/413
(100 %)
1 diff
(99.8 %id)
DN918684   .a 2717 to 3169 1 to 453       453/453
(100 %)
16 diff
(96.5 %id)
BU598888 mixed (pool of 40 RNAs) .a 2876 to 3583 1 to 711       711/778
(91 %)
21 diff
(97.4 %id)
DA728509   .a 2889 to 3731 2 to 845   capped   844/844
(100 %)
15 diff
(98.3 %id)
BG286810 bladder, transitional cell papilloma, cell line .a 2918 to 3707 1 to 787       787/814
(96 %)
32 diff
(96.1 %id)
CV801619 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2920 to 3635 1 to 708       708/813
(87 %)
13 diff
(98.5 %id)
CB270201 adipose .a 2969 to 3387 1 to 417       417/417
(100 %)
2 diff
(99.6 %id)
F12705 brain, total brain .a 2974 to 3281 1 to 308       308/308
(100 %)
3 diff
(99.1 %id)
BM711478 eye, fetal eyes .a 2994 to 3539 1 to 546       546/546
(100 %)
0 diff
(100 %id)
FN058622 breast carcinoma .a 3013 to 3065 1 to 53       53/54
(98 %)
1 diff
(98.2 %id)
R21138 whole brain .a 3020 to 3328 1 to 322       322/335
(96 %)
21 diff
(93.8 %id)
BI092346 cervix .a 3033 to 3790 1 to 768       768/768
(100 %)
21 diff
(97.3 %id)
T75035 whole brain .a 3037 to 3379 1 to 341       341/343
(99 %)
7 diff
(98.0 %id)
CB150536 cervix, Uterine .a 3057 to 3584 1 to 528       528/528
(100 %)
4 diff
(99.3 %id)
AA351620 brain .a 3063 to 3378 1 to 316       316/316
(100 %)
0 diff
(100 %id)
H16882 whole brain .a 3063 to 3501 1 to 445       445/452
(98 %)
9 diff
(98.1 %id)
BG678954 skin, squamous cell carcinoma .a 3068 to 3885 1 to 833       833/833
(100 %)
27 diff
(96.8 %id)
BE387500 melanotic melanoma, skin .a 3071 to 3703 26 to 657       632/657
(96 %)
6 diff
(99.1 %id)
DA075597 cerebellum .a 3081 to 3647 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BG281717 melanotic melanoma, skin .a 3086 to 3976 1 to 877       877/927
(94 %)
26 diff
(97.2 %id)
BG477655 melanotic melanoma, skin .a 3086 to 3930 1 to 859       859/860
(99 %)
23 diff
(97.4 %id)
DB009310 colon, tumor tissue .a 3088 to 3648 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BE386928 melanotic melanoma, skin .a 3097 to 3674 6 to 586       581/586
(99 %)
8 diff
(98.7 %id)
AW631117 2 pooled high-grade transitional celltumors, genitourinary tract .a 3134 to 3499 1 to 366       366/366
(100 %)
0 diff
(100 %id)
CR985939 T-Lymphocytes .a 3137 to 3991 1 to 858       858/858
(100 %)
5 diff
(99.5 %id)
EL955472 eyeball .a 3139 to 3320 35 to 215       181/215
(84 %)
6 diff
(97.3 %id)
BE302419 melanotic melanoma, skin .a 3156 to 3486 1 to 331       331/331
(100 %)
3 diff
(99.1 %id)
DB341000 testis .a 4113 to 4650 539 to 1       539/539
(100 %)
1 diff
(99.9 %id)
DB361398 mammary gland .a 4164 to 4650 486 to 1       486/515
(94 %)
8 diff
(98.5 %id)
BM670727 eye, fetal eyes .a 4245 to 4650 422 to 17   AAA   406/406
(100 %)
0 diff
(100 %id)
H16773 whole brain .a 4315 to 4650 365 to 24   AAA   342/342
(100 %)
11 diff
(96.8 %id)
R43650 whole brain .a 4382 to 4650 284 to 12   AAA   273/280
(97 %)
8 diff
(97.2 %id)
R46733 whole brain .a 4436 to 4650 227 to 13   AAA   215/215
(100 %)
0 diff
(100 %id)
F10313 brain, total brain .a 4449 to 4650 202 to 1       202/202
(100 %)
0 diff
(100 %id)
AK299509 brain .b 1 to 1196 1 to 1196 E81Q tiling clone,   1196/1196
(100 %)
4 diff
(99.7 %id)
DC374241 brain .b 1 to 571 1 to 571       571/571
(100 %)
2 diff
(99.7 %id)
BE315494 adenocarcinoma cell line, ovary .c 1 to 679 40 to 724   tiling clone,   685/725
(94 %)
10 diff
(98.7 %id)
BE747817 adenocarcinoma cell line, ovary .c 2 to 626 49 to 696 K6I P7T D8R E9* tiling clone,   723/1028
(70 %)
47 diff
(95.5 %id)
DA231036 brain .d 1 to 520 2 to 520 exact tiling clone, capped   519/519
(100 %)
1 diff
(99.9 %id)
BP379823 uterus .e 1 to 554 1 to 555 M6V E7G L9A N10Q N11* tiling clone,   555/556
(99 %)
23 diff
(95.9 %id)
CX762136 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 125 to 839 1 to 710   tiling clone, Submitted on the opposite strand 710/851
(83 %)
7 diff
(99.2 %id)
BX509139   .e 355 to 985 1 to 631   tiling clone,   631/631
(100 %)
1 diff
(99.9 %id)
BX509252   .e 355 to 943 1 to 589       589/589
(100 %)
1 diff
(99.9 %id)
DA043706 bladder .e 469 to 1037 2 to 570   tiling clone, capped   569/569
(100 %)
1 diff
(99.9 %id)
DA427455 colon .f-u 1 to 477 2 to 482   tiling clone, capped   481/481
(100 %)
5 diff
(99.0 %id)
BU171610 melanotic melanoma, skin .f-u 29 to 848 1 to 822       822/823
(99 %)
10 diff
(98.8 %id)
BU844411 ovary, teratocarcinoma, cell line .f-u 39 to 932 1 to 902   tiling clone,   902/903
(99 %)
15 diff
(98.4 %id)
N40824 placenta .f-u 93 to 457 1 to 364       364/364
(100 %)
5 diff
(98.7 %id)
CF144339 CNCAP(3)T-225 cell line, Prostate .f-u 128 to 605 1 to 477       477/477
(100 %)
9 diff
(98.2 %id)
CF144419 CNCAP(3)T-225 cell line, Prostate .f-u 128 to 672 1 to 545       545/545
(100 %)
5 diff
(99.1 %id)
CF144810 CNCAP(3)T-225 cell line, Prostate .f-u 128 to 571 1 to 444       444/444
(100 %)
4 diff
(99.1 %id)
TI_154176339   .f-u 134 to 642 79 to 582       504/779
(64 %)
14 diff
(98.3 %id)
TI_154176435   .f-u 134 to 722 79 to 670       592/1211
(48 %)
8 diff
(99.4 %id)
TI_154176900   .f-u 134 to 665 80 to 610   tiling clone,   531/531
(100 %)
2 diff
(99.7 %id)
DN912399   .f-u 164 to 583 1 to 420       420/420
(100 %)
4 diff
(99.1 %id)
DN919953   .f-u 164 to 720 1 to 556       556/556
(100 %)
3 diff
(99.5 %id)
AA355276   .f-u 168 to 445 1 to 277       277/278
(99 %)
3 diff
(99.0 %id)
AW953402   .f-u 169 to 710 1 to 543       543/546
(99 %)
17 diff
(96.9 %id)
Z17889   .f-u 173 to 485 312 to 1       312/314
(99 %)
3 diff
(99.1 %id)
BM713935 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 187 to 669 1 to 483       483/483
(100 %)
1 diff
(99.8 %id)
BX480269   .f-u 196 to 757 1 to 561       561/561
(100 %)
3 diff
(99.5 %id)
FN069176 breast carcinoma .f-u 203 to 306 104 to 1     Submitted on the opposite strand 104/104
(100 %)
0 diff
(100 %id)
CR993028 T-Lymphocytes .f-u 303 to 1106 1 to 806       806/806
(100 %)
2 diff
(99.8 %id)
DN912398   .f-u 341 to 879 538 to 1       538/538
(100 %)
3 diff
(99.5 %id)
BE180450 head_neck .f-u 369 to 765 20 to 415       396/416
(95 %)
15 diff
(96.4 %id)
CB158364 Liver .f-u 397 to 770 1 to 374       374/374
(100 %)
0 diff
(100 %id)
CB159259 Liver .f-u 397 to 655 1 to 260       260/260
(100 %)
12 diff
(95.4 %id)
CB987548 Pooled-Glandular .f-u 410 to 1045 1 to 643       643/744
(86 %)
12 diff
(98.4 %id)
BM707067 eye, eye anterior segment .f-u 470 to 1056 1 to 587   fully sequenced,   587/587
(100 %)
5 diff
(99.2 %id)
FN092180 breast carcinoma .f-u 482 to 555 1 to 73       73/74
(98 %)
2 diff
(97.3 %id)
AA838157 ovary .f-u 488 to 905 1 to 417       417/417
(100 %)
1 diff
(99.8 %id)
EC482170 Prostate .f-u 507 to 606 97 to 1       97/97
(100 %)
5 diff
(94.9 %id)
EC495904 Prostate .f-u 507 to 606 98 to 1       98/98
(100 %)
2 diff
(98.0 %id)
EC554639 Prostate .f-u 507 to 606 100 to 1       100/100
(100 %)
2 diff
(98.0 %id)
EC568710 Prostate .f-u 507 to 606 100 to 1       100/100
(100 %)
0 diff
(100 %id)
BM720855 eye, fetal eye .f-u 508 to 1260 1 to 753   tiling clone,   753/753
(100 %)
5 diff
(99.4 %id)
EC496079 Prostate .f-u 509 to 608 99 to 1       99/99
(100 %)
3 diff
(97.0 %id)
EC539278 Prostate .f-u 509 to 608 100 to 1       100/100
(100 %)
0 diff
(100 %id)
BE272406 adenocarcinoma cell line, ovary .f-u 513 to 1109 18 to 614       597/614
(97 %)
6 diff
(99.1 %id)
EC466535 Prostate .f-u 520 to 608 90 to 1       90/99
(90 %)
1 diff
(99.0 %id)
EC495761 Prostate .f-u 520 to 608 88 to 1       88/97
(90 %)
1 diff
(99.0 %id)
BE272472 adenocarcinoma cell line, ovary .f-u 520 to 1115 41 to 634       594/634
(93 %)
6 diff
(99.1 %id)
BM720748 eye, fetal eye .f-u 530 to 1280 1 to 749       749/749
(100 %)
2 diff
(99.8 %id)
TI_149314990   .f-u 536 to 1473 1038 to 110 S25F I32V T40K     929/1111
(83 %)
0 diff
(100 %id)
EC495558 Prostate .f-u 547 to 649 100 to 1       100/100
(100 %)
3 diff
(97.0 %id)
EC510754 Prostate .f-u 547 to 649 103 to 1       103/103
(100 %)
0 diff
(100 %id)
R96563 liver and spleen .f-u 575 to 974 1 to 405       405/435
(93 %)
11 diff
(97.5 %id)
BM825149 Ascites, stomach .f-u 575 to 1052 1 to 478       478/478
(100 %)
1 diff
(99.8 %id)
DN918683   .f-u 585 to 879 295 to 1       295/295
(100 %)
1 diff
(99.7 %id)
BX374314   .f-u 595 to 1438 852 to 5 Y48*     848/858
(98 %)
0 diff
(100 %id)
EC450240 Prostate .f-u 609 to 704 112 to 20       93/112
(83 %)
0 diff
(100 %id)
BG480592 choriocarcinoma, placenta .f-u 621 to 1469 1 to 852 exact AAA   852/852
(100 %)
8 diff
(99.1 %id)
TI_149293145   .f-u 649 to 1471 875 to 61 Y54F AAA   815/820
(99 %)
13 diff
(98.5 %id)
BM044947 carcinoma, cell line, Prostate .f-u 662 to 1469 1 to 807 exact AAA   807/807
(100 %)
5 diff
(99.4 %id)
BU623979 cell lines, Enchondroma .f-u 672 to 1471 815 to 19 exact AAA   797/797
(100 %)
3 diff
(99.7 %id)
TI_154095831   .f-u 690 to 1471 867 to 95 exact AAA   773/966
(80 %)
27 diff
(97.3 %id)
AA203663 liver and spleen .f-u 697 to 1225 1 to 530       530/865
(61 %)
26 diff
(97.0 %id)
BF327058 breast_normal .f-u 698 to 1243 551 to 6       546/562
(97 %)
0 diff
(100 %id)
EC528605 Prostate .f-u 699 to 792 103 to 9       95/103
(92 %)
0 diff
(100 %id)
BE170710 head_neck .f-u 707 to 1270 563 to 1     Submitted on the opposite strand 563/563
(100 %)
2 diff
(99.7 %id)
W22559 eye, retina .f-u 746 to 1265 539 to 12       528/754
(70 %)
0 diff
(100 %id)
BM676551 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 773 to 1469 717 to 19 exact AAA   699/699
(100 %)
3 diff
(99.6 %id)
CA306481 Alveolar Macrophage, lung .f-u 774 to 1469 715 to 19 exact AAA   697/697
(100 %)
1 diff
(99.9 %id)
CA450404 Human Lung Epithelial cells, lung .f-u 782 to 1471 706 to 17 exact AAA   690/690
(100 %)
2 diff
(99.8 %id)
BU625840 cell lines, Enchondroma .f-u 782 to 1471 708 to 19 exact AAA   690/690
(100 %)
2 diff
(99.8 %id)
BQ446393 Knee, Osteoarthritic Cartilage .f-u 805 to 1471 684 to 17 exact AAA   668/668
(100 %)
1 diff
(99.9 %id)
CN479189 lung, Primary Lung Cystic Fibrosis EpithelialCells .f-u 815 to 1471 674 to 17 S25F I32V T40K AAA   658/658
(100 %)
12 diff
(98.2 %id)
CA427149 Bone, Subchondral Bone .f-u 815 to 1469 674 to 19 exact AAA   656/656
(100 %)
1 diff
(99.9 %id)
CA424192 cell lines, Chondrosarcoma .f-u 819 to 1469 669 to 19 exact AAA   651/651
(100 %)
0 diff
(100 %id)
CK904965 Islets of Langerhans, Pancreas .f-u 822 to 1386 1 to 565 exact     565/565
(100 %)
0 diff
(100 %id)
TI_159703011   .f-u 827 to 1471 731 to 87 S13R L16F F38E Y54* AAA   645/1041
(61 %)
26 diff
(97.6 %id)
EC560836 Prostate .f-u 837 to 938 7 to 106       100/106
(94 %)
2 diff
(98.2 %id)
BM128733 Islets of Langerhans, Pancreas .f-u 838 to 1290 1 to 453       453/453
(100 %)
0 diff
(100 %id)
BM129156 Islets of Langerhans, Pancreas .f-u 838 to 1398 1 to 561 exact     561/561
(100 %)
0 diff
(100 %id)
BU628319 Bone, Enchondroma cell line .f-u 854 to 1471 636 to 19 exact AAA   618/627
(98 %)
0 diff
(100 %id)
AW025332 Kidney .f-u 869 to 1469 624 to 23 F45V Q46* AAA   602/602
(100 %)
4 diff
(99.4 %id)
CA430023 Cell Line, Chondrosarcoma .f-u 872 to 1471 617 to 17 exact AAA   601/601
(100 %)
1 diff
(99.9 %id)
BG329588 eye, retinoblastoma .f-u 874 to 1474 1 to 598 L44C Q46R K47N Y48M V49Y ... AAA   598/598
(100 %)
4 diff
(99.4 %id)
BG473164 eye, retinoblastoma .f-u 874 to 1471 1 to 597 exact AAA   597/597
(100 %)
4 diff
(99.4 %id)
BU682489 lung .f-u 876 to 1471 612 to 17 Y54F AAA   596/596
(100 %)
1 diff
(99.9 %id)
CA433088 mixed .f-u 885 to 1471 602 to 17 exact AAA   586/586
(100 %)
1 diff
(99.9 %id)
W47080 senescent fibroblast .f-u 889 to 1353 10 to 472 G2V V3*     463/472
(98 %)
6 diff
(98.8 %id)
BX102115 senescent fibroblast .f-u 895 to 1457 1 to 563 R34C     563/563
(100 %)
1 diff
(99.9 %id)
AA449602   .f-u 895 to 1209 1 to 315   fully sequenced,   315/315
(100 %)
4 diff
(98.8 %id)
BE707416 head_neck .f-u 909 to 1271 383 to 10       374/383
(97 %)
0 diff
(100 %id)
DV461491 cochlea, ear .f-u 930 to 1332 403 to 1 W63*   Submitted on the opposite strand 403/403
(100 %)
2 diff
(99.6 %id)
CB149901 Liver .f-u 934 to 1386 1 to 454 Q7H T8I H9Y V49R     454/454
(100 %)
60 diff
(86.8 %id)
BU631937 cell lines, Chondrosarcoma .f-u 935 to 1471 553 to 17 exact AAA   537/537
(100 %)
0 diff
(100 %id)
FN071870 breast carcinoma .f-u 983 to 1083 1 to 101       101/101
(100 %)
0 diff
(100 %id)
AA829945 germinal center B cell .f-u 987 to 1471 503 to 18 G10X W11V R12A S13Q C14L ... AAA   486/486
(100 %)
2 diff
(99.6 %id)
AW665097 pooled .f-u 988 to 1472 485 to 1 exact     485/485
(100 %)
0 diff
(100 %id)
AI128091 uterus .f-u 989 to 1471 493 to 11 exact AAA   483/483
(100 %)
0 diff
(100 %id)
AI344208 colon, colon tumor, RER+ .f-u 989 to 1471 511 to 29 S13N L16X AAA   483/483
(100 %)
4 diff
(99.2 %id)
AW172323 pooled .f-u 989 to 1473 487 to 3 exact     485/487
(99 %)
0 diff
(100 %id)
AW809916 stomach .f-u 992 to 1163 1 to 171       171/171
(100 %)
8 diff
(95.4 %id)
AW387951 stomach .f-u 993 to 1163 20 to 187       168/187
(89 %)
6 diff
(96.8 %id)
AW609111 stomach .f-u 993 to 1163 1 to 170       170/170
(100 %)
5 diff
(97.1 %id)
AA558424 germ cell tumor .f-u 993 to 1469 490 to 14 G10A AAA   477/477
(100 %)
2 diff
(99.6 %id)
BF374593 stomach .f-u 994 to 1163 14 to 184       171/184
(92 %)
6 diff
(96.8 %id)
AI332592 lung .f-u 995 to 1470 476 to 1 exact     476/476
(100 %)
0 diff
(100 %id)
TI_154167649   .f-u 1000 to 1473 563 to 90 exact   Submitted on the opposite strand 474/484
(97 %)
0 diff
(100 %id)
AI379522 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1002 to 1473 474 to 3 exact     472/474
(99 %)
0 diff
(100 %id)
AW810600 stomach .f-u 1003 to 1289 1 to 287       287/287
(100 %)
6 diff
(98.0 %id)
CA310416 cell lines, Chondrosarcoma .f-u 1003 to 1471 485 to 17 exact AAA   469/469
(100 %)
0 diff
(100 %id)
DB536185 hippocampus .f-u 1007 to 1469 1 to 462 G2V V3*   Submitted on the opposite strand 462/462
(100 %)
16 diff
(96.6 %id)
AA724234 parathyroid gland, parathyroid tumor .f-u 1008 to 1473 469 to 5 W6*     465/469
(99 %)
0 diff
(100 %id)
AW073744 2 pooled high-grade transitional celltumors, genitourinary tract .f-u 1011 to 1471 477 to 16 V49G L51P S53L Y54I L56F ... AAA   462/462
(100 %)
2 diff
(99.6 %id)
DB520230 testis .f-u 1018 to 1471 1 to 454 exact   Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
CF137921 lymph .f-u 1020 to 1473 471 to 18 exact   Submitted on the opposite strand 454/471
(96 %)
0 diff
(100 %id)
DV462304 cochlea, ear .f-u 1020 to 1332 313 to 1 exact   Submitted on the opposite strand 313/313
(100 %)
1 diff
(99.7 %id)
BE842266 stomach .f-u 1024 to 1163 1 to 139       139/139
(100 %)
5 diff
(96.5 %id)
AI140440 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1025 to 1471 459 to 13 R34C AAA   447/447
(100 %)
1 diff
(99.8 %id)
AI271642 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1025 to 1473 453 to 5 exact     449/453
(99 %)
0 diff
(100 %id)
AI570618 anaplastic oligodendroglioma, brain .f-u 1025 to 1471 447 to 1 exact     447/447
(100 %)
0 diff
(100 %id)
AW148745 brain, tumor, 5 pooled (see description) .f-u 1025 to 1469 478 to 33 A4T R12G I32K Y48K V49G ... AAA   446/446
(100 %)
28 diff
(93.8 %id)
BM673238 eye, eye anterior segment .f-u 1026 to 1478 471 to 19 exact tiling clone, fully sequenced, AAA   453/453
(100 %)
0 diff
(100 %id)
DB558645 hypothalamus .f-u 1030 to 1471 1 to 442 L16F   Submitted on the opposite strand 442/442
(100 %)
2 diff
(99.6 %id)
W00616 multiple sclerosis lesions .f-u 1030 to 1574 1 to 526 W6X Q7R S13X C14A L15C ... tiling clone,   526/544
(96 %)
59 diff
(89.2 %id)
AI343766 2 pooled tumors (clear cell type), Kidney .f-u 1033 to 1473 442 to 2 exact     441/442
(99 %)
0 diff
(100 %id)
AW305376 brain, three pooled meningiomas .f-u 1035 to 1472 438 to 1 exact     438/438
(100 %)
0 diff
(100 %id)
AI344640 2 pooled tumors (clear cell type), Kidney .f-u 1045 to 1473 433 to 5 exact     429/433
(99 %)
0 diff
(100 %id)
AI370859   .f-u 1049 to 1473 426 to 2 exact     425/426
(99 %)
0 diff
(100 %id)
AI799429 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .f-u 1049 to 1471 437 to 15 exact AAA   423/423
(100 %)
0 diff
(100 %id)
DW453865 Liver .f-u 1098 to 1265 17 to 184       168/184
(91 %)
6 diff
(96.8 %id)
DW465617 Liver .f-u 1098 to 1437 17 to 356 exact     340/356
(95 %)
6 diff
(98.4 %id)
AA746222 2 pooled tumors (clear cell type), Kidney .f-u 1100 to 1471 388 to 18 W11G R12A S13A C14A L15C ... AAA   371/371
(100 %)
1 diff
(99.8 %id)
CA335441 posterior tongue (pooled) .f-u 1101 to 1469 1 to 369 exact AAA   369/369
(100 %)
0 diff
(100 %id)
CA336079 anterior rhombomeres 1-4 (4 pooled) .f-u 1101 to 1471 1 to 371 exact AAA   371/371
(100 %)
0 diff
(100 %id)
CA338075 1st pharyngeal arch (pooled) .f-u 1101 to 1469 1 to 369 exact AAA   369/369
(100 %)
1 diff
(99.8 %id)
CB856785 anterior tongue, pooled .f-u 1101 to 1469 1 to 369 exact AAA   369/369
(100 %)
0 diff
(100 %id)
EC515872 Prostate .f-u 1102 to 1185 13 to 98       86/98
(87 %)
6 diff
(93.9 %id)
AI284278 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1102 to 1473 377 to 5 exact     373/377
(98 %)
0 diff
(100 %id)
DV462539 cochlea, ear .f-u 1110 to 1334 226 to 2     Submitted on the opposite strand 225/226
(99 %)
0 diff
(100 %id)
EC516998 Prostate .f-u 1114 to 1195 1 to 82       82/82
(100 %)
3 diff
(96.4 %id)
AI688886 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f-u 1116 to 1469 371 to 18   AAA   354/354
(100 %)
0 diff
(100 %id)
AI335749 pooled germ cell tumors .f-u 1117 to 1472 357 to 1       357/357
(100 %)
3 diff
(99.2 %id)
AI753770 bone marrow stroma .f-u 1124 to 1471 370 to 23   AAA   348/348
(100 %)
0 diff
(100 %id)
AI313415 lung .f-u 1132 to 1473 346 to 5       342/346
(98 %)
0 diff
(100 %id)
AA564697 adrenal adenoma, adrenal gland .f-u 1135 to 1473 340 to 2       339/340
(99 %)
0 diff
(100 %id)
AA829787 carcinoid, lung .f-u 1135 to 1472 338 to 1       338/338
(100 %)
0 diff
(100 %id)
AA960941 carcinoid, lung .f-u 1136 to 1470 335 to 1       335/335
(100 %)
0 diff
(100 %id)
AA552138 colon .f-u 1137 to 1472 336 to 1       336/336
(100 %)
1 diff
(99.8 %id)
AA768148 germinal center B cell .f-u 1137 to 1471 346 to 12   AAA   335/335
(100 %)
0 diff
(100 %id)
AA844390 parathyroid gland, parathyroid tumor .f-u 1137 to 1473 341 to 5       337/341
(98 %)
0 diff
(100 %id)
DB535311 hippocampus .f-u 1138 to 1469 1 to 333     Submitted on the opposite strand 333/333
(100 %)
9 diff
(97.3 %id)
AA574224 breast .f-u 1140 to 1472 333 to 1       333/333
(100 %)
0 diff
(100 %id)
AI056257 liver and spleen .f-u 1144 to 1473 334 to 5       330/334
(98 %)
0 diff
(100 %id)
AA988314 breast .f-u 1152 to 1469 342 to 25   AAA   318/318
(100 %)
0 diff
(100 %id)
BU738762 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 1155 to 1469 333 to 19   AAA   315/315
(100 %)
0 diff
(100 %id)
AA027114 uterus .f-u 1156 to 1471 317 to 1       317/317
(100 %)
1 diff
(99.7 %id)
DB557719 hypothalamus .f-u 1166 to 1469 12 to 319     Submitted on the opposite strand 308/319
(96 %)
6 diff
(98.2 %id)
AI038229 senescent fibroblast .f-u 1172 to 1473 307 to 6       302/307
(98 %)
0 diff
(100 %id)
AA449343   .f-u 1179 to 1478 300 to 1   fully sequenced,   300/300
(100 %)
5 diff
(98.4 %id)
AA760625 germinal center B cell .f-u 1199 to 1469 294 to 24   AAA   271/271
(100 %)
0 diff
(100 %id)
AI357357 brain, glioblastoma (pooled) .f-u 1209 to 1473 272 to 8       265/272
(97 %)
0 diff
(100 %id)
AW072929 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .f-u 1209 to 1471 274 to 12   AAA   263/263
(100 %)
0 diff
(100 %id)
AA741538 2 pooled tumors (clear cell type), Kidney .f-u 1218 to 1473 261 to 6       256/261
(98 %)
0 diff
(100 %id)
AI197799 anaplastic oligodendroglioma, brain .f-u 1221 to 1473 254 to 2       253/254
(99 %)
0 diff
(100 %id)
CF137746 lymph .f-u 1232 to 1473 265 to 23     Submitted on the opposite strand 243/271
(89 %)
0 diff
(100 %id)
AW183367 pooled .f-u 1257 to 1471 230 to 15   AAA   216/216
(100 %)
5 diff
(97.7 %id)
AI432022 adenocarcinoma, Pancreas .f-u 1265 to 1469 230 to 26   AAA   205/205
(100 %)
4 diff
(98.1 %id)
R96518 liver and spleen .f-u 1269 to 1459 191 to 1       191/191
(100 %)
1 diff
(99.5 %id)
DB560049 hypothalamus .f-u 1320 to 1471 1 to 154     Submitted on the opposite strand 154/154
(100 %)
2 diff
(98.8 %id)
AI205866 lung .f-u 1323 to 1473 151 to 1       151/151
(100 %)
1 diff
(99.4 %id)
BQ010493 Chondrosarcoma, Left Pubic Bone .f-u 1367 to 1789 441 to 19   tiling clone, AAA   423/423
(100 %)
13 diff
(97.0 %id)
FN141182 breast carcinoma .f-u 1381 to 1465 1 to 82       82/87
(94 %)
5 diff
(94.3 %id)
AA190209   .f-u 1395 to 1473 10 to 88       79/95
(83 %)
1 diff
(99.0 %id)
AA585377   .f-u 1411 to 1466 1 to 55       55/60
(91 %)
1 diff
(98.4 %id)
BQ631332 Pancreas, Purified pancreatic islet .g-u 1 to 174 174 to 1 exact tiling clone,   174/174
(100 %)
0 diff
(100 %id)
AA331794 Embryo, 8 weeks Gene C20orf11, variant not shown              
AW962564   Gene C20orf11, variant not shown              
DB304577 brain Gene C20orf11, variant not shown         This clone was ignored    
DA213672 brain Gene C20orf11, variant not shown       capped This clone was ignored    
CN267961 embryonic stem cells, cell lines H1, H7, andH9 Gene C20orf11, variant not shown              
BX490867   Gene C20orf11, variant not shown              
AL708197 human skeletal muscle Gene C20orf11, variant not shown              
DB315902 brain Gene C20orf11, variant not shown              
DA501945 brain Gene C20orf11, variant not shown       capped      
BJ990304 hepatoblastoma Gene C20orf11, variant not shown         Suspected internal deletion, this clone was ignored    
BJ990305 hepatoblastoma Gene C20orf11, variant not shown         Suspected internal deletion, this clone was ignored    
T49241 placenta Gene C20orf11, variant not shown              
T49242 placenta Gene C20orf11, variant not shown              
CB049485 Prostate Gene C20orf11, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CB049486 Prostate Gene C20orf11, variant not shown         Suspected internal deletion, this clone was ignored    
BG682349 skin, squamous cell carcinoma Gene C20orf11, variant not shown         Suspected internal deletion, this clone was ignored    
BM045278 carcinoma, cell line, Prostate Gene C20orf11, variant not shown              
BM826843 Ascites, stomach Gene C20orf11, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI